Brian Markison
Overview
Brian Markison received an average of $2M in total compensation, including $639K in salary, at RVL Pharmaceuticals plc from 2017 to 2022.
2022RVL Pharmaceuticals plcPresident, Chief Executive Officer and Principal Financial Officer
2021RVL Pharmaceuticals plcPresident and Chief Executive Officer
2020RVL Pharmaceuticals plcPresident and Chief Executive Officer
2019RVL Pharmaceuticals plcPresident and Chief Executive Officer
2018RVL Pharmaceuticals plcPresident and Chief Executive Officer
2017RVL Pharmaceuticals plcPresident and Chief Executive Officer
Source: SEC filings on April 24, 2023, April 25, 2022, April 26, 2021, April 20, 2020, and April 26, 2019.
Related executives
We found four more executives who work or worked at RVL Pharmaceuticals plc.
News
RVL Pharmaceuticals plc Former EVP, Research & Development Tina deVries' 2022 pay slips 19% to $561K
April 24, 2023
RVL Pharmaceuticals plc CEO Brian Markison's 2021 pay falls 63% to $1.4M
April 25, 2022
RVL Pharmaceuticals plc CEO Brian Markison's 2020 pay slips 12% to $3.8M
April 26, 2021
RVL Pharmaceuticals plc CEO Brian Markison's 2019 pay jumps 291% to $4.3M
April 20, 2020
RVL Pharmaceuticals plc CEO Brian Markison's 2018 pay slips 10% to $1.1M
April 26, 2019